NCT04246203View on ClinicalTrials.gov

Prognostic Role of Circulating Tumor DNA in Resectable Pancreatic Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

December 12, 2021

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2026

Conditions
Pancreas Cancer
Interventions
OTHER

Liquid Biopsy

17-20 ml of blood will be collected prior of surgery and within 14 days before start of adjuvant chemotherapy.

Trial Locations (6)

80333

Technische Universität München, Munich

80799

Ludwig Maximilians University Munich, Munich

Unknown

Charité - Universitätsmedizin Berlin, Berlin

Uniklinik Köln, Cologne

Universitätsklinikum Hamburg-Eppendorf, Hamburg

Universitätsklinikum Ulm, Ulm

All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

lead

Ludwig-Maximilians - University of Munich

OTHER